Latest Breaking News On - Nevro daily - Page 9 : comparemela.com

Nevro Corp (NYSE:NVRO) Receives $30 62 Average Price Target from Analysts

Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Hold” from the fourteen brokerages that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and four have issued a buy recommendation on the company. The average […]

United statesJpmorgan chase coMillennium managementNevro company profileNorges bankArrowmark colorado holdingsNevro corpBlackrock incGet free reportMark colorado holdingsGet freeSenza omniaNevro dailyNyse nvro

ProSomnus (NASDAQ:OSA) and Nevro (NYSE:NVRO) Financial Review

ProSomnus (NASDAQ:OSA) and Nevro (NYSE:NVRO) Financial Review
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United statesRedwood cityProsomnus incNevro corpGet free reportGiven prosomnuSenza omniaNevro daily

Swiss National Bank Sells 8,500 Shares of Nevro Corp (NYSE:NVRO)

Swiss National Bank decreased its position in shares of Nevro Corp. (NYSE:NVRO – Free Report) by 10.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 72,600 shares of the medical equipment provider’s stock after selling 8,500 shares during the period. Swiss National […]

United statesShawn mccormickCapital partnersJpmorgan chase coMorgan stanleyNevro company profileSwiss national bankWells fargo companyCapital fund managementFranklin resources incNevro corpSecurities exchange commissionArrowmark colorado holdingsFree reportNational bankMark colorado holdings

Citigroup Cuts Nevro (NYSE:NVRO) Price Target to $21 00

Nevro (NYSE:NVRO – Free Report) had its price target reduced by Citigroup from $24.00 to $21.00 in a research report report published on Monday morning, Marketbeat.com reports. They currently have a neutral rating on the medical equipment provider’s stock. A number of other brokerages have also recently issued reports on NVRO. Truist Financial lowered their […]

United statesHong kongShawn mccormickPiper sandlerHong kong ltdSecurities exchange commissionCanaccord genuity groupAssetmark incNevro corpWells fargo companyFree reportGenuity groupWells fargoTrading downGet free reportDirector shawn mccormick

Nevro (NYSE:NVRO) Given Outperform Rating at Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Nevro (NYSE:NVRO – Free Report) in a report released on Thursday morning, Benzinga reports. Royal Bank of Canada currently has a $33.00 target price on the medical equipment provider’s stock. A number of other equities research analysts have also recently commented on NVRO. StockNews.com […]

United statesShawn mccormickSecurities exchange commissionAssetmark incJpmorgan chase coTower research capitalCanaccord genuity groupWells fargo companyNevro company profileRoyal bankNevro corpFree reportGenuity groupGet free reportDirector shawn mccormickExchange commission